| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 72,769 | |||
| Short-term investments | 12,504 | |||
| Accounts receivable, net | 217,896 | |||
| Inventories, net | 471,775 | |||
| Other current assets | 60,855 | |||
| Total current assets | 835,799 | |||
| Property, plant and equipment, net | 354,780 | |||
| Intangibles, net | 34,964 | |||
| Goodwill | 59,708 | |||
| Other assets | 100,273 | |||
| Total assets | 1,385,524 | |||
| Current portion of long-term debt | 18,444 | |||
| Accounts payable | 130,597 | |||
| Accrued expenses and other current liabilities | 121,098 | |||
| Total current liabilities | 270,139 | |||
| Revolving credit facility | 115,000 | |||
| Long-term debt | 609,518 | |||
| Other liabilities | 79,186 | |||
| Total liabilities | 1,073,843 | |||
| Common stock, par value 0.0001 per share 300,000,000 class a shares authorized, 20,397,574 and 20,367,574 shares issued and outstanding at september 30, 2025 and june 30, 2025, respectively 30,000,000 class b shares authorized, 20,136,034 and 20,166,034 shares issued and outstanding at september 30, 2025 and june 30, 2025, respectively | 4 | |||
| Paid-in capital | 137,334 | |||
| Retained earnings | 294,364 | |||
| Accumulated other comprehensive loss | -120,021 | |||
| Total stockholders' equity | 311,681 | |||
| Total liabilities and stockholders' equity | 1,385,524 | |||
PHIBRO ANIMAL HEALTH CORP (PAHC)
PHIBRO ANIMAL HEALTH CORP (PAHC)